Back

A Genome-wide Association study of Buccal Mucosa Cancer in India and Multi-ancestry Meta-analysis Identifies Novel Risk Loci and Gene-environment Interactions

Mhatre, S.; Dutta, D.; Iyer, A.; George, G.; Sagare, S.; Singh, A.; Mishra, A.; Krishnatreya, M.; Panse, N.; Dun, Y.; Wang, Z.; Jahagirdar, O.; Chaturvedi, P.; Rajaraman, P.; Wang, C.-P.; Chaturvedi, A.; Kar, S.; Dikshit, R.; Chatterjee, N.

2025-04-17 oncology
10.1101/2025.04.16.25325815
Show abstract

Genome-wide association studies (GWAS) of oral cancers (OC) to date have focused predominantly on European Ancestry (EA) populations. India faces an excess burden of OC, but the most common site of occurrence is the cancer of the buccal mucosa, which is relatively rare in EA populations. We conducted a GWAS of buccal mucosa cancer (BMC) comprising 2,160 BMC cases and 2,325 controls from different geographical locations in India. Single-SNP association tests detected one novel locus (6q27) and one novel signal within the known OC risk locus 5p13.33, at the genome-wide significance level (P-value<5X10-8). We additionally conducted a GWAS of 397 BMC cases and 439 controls from Taiwan and performed multi-ancestry GWAS meta-analysis of OC on 5255 cases and 8748 controls across EA, Indian and Taiwanese populations. We identified a novel risk locus harbouring the tumour suppressor gene NOTCH1 through a gene-level analysis of the multi-ancestry GWAS data. Pathway analysis suggested that PD-1 signalling, and Interferon Gamma Signalling may be important in the aetiology of BMC. Within data from the Indian BMC GWAS, we further identified statistically significant evidence of both multiplicative interactions (P-value=0.026) indicating stronger polygenic risk of BMC among individuals with history of chewing tobacco compared to those without. Our study provides insights into the etiologies of BMC in India, highlighting both its similarities and differences with other types of oral cavity cancers, as well as the interactions between polygenic gene score and tobacco chewing.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Cancer Epidemiology, Biomarkers & Prevention
based on 14 papers
Top 0.1%
9.7%
2
Nature Communications
based on 483 papers
Top 9%
9.7%
3
Cancers
based on 57 papers
Top 2%
9.7%
4
Nature Genetics
based on 72 papers
Top 2%
7.2%
5
eLife
based on 262 papers
Top 4%
5.1%
6
Scientific Reports
based on 701 papers
Top 44%
4.3%
7
PLOS ONE
based on 1737 papers
Top 74%
4.3%
50% of probability mass above
8
Frontiers in Oncology
based on 34 papers
Top 3%
2.7%
9
Cancer Medicine
based on 17 papers
Top 2%
2.3%
10
Clinical Epigenetics
based on 21 papers
Top 0.7%
2.2%
11
Clinical Cancer Research
based on 22 papers
Top 2%
2.2%
12
Communications Biology
based on 36 papers
Top 1%
2.2%
13
BMC Cancer
based on 21 papers
Top 2%
2.2%
14
International Journal of Cancer
based on 18 papers
Top 0.9%
2.2%
15
British Journal of Cancer
based on 22 papers
Top 2%
2.2%
16
Gut
based on 17 papers
Top 1%
1.7%
17
JNCI: Journal of the National Cancer Institute
based on 13 papers
Top 1%
1.5%
18
Breast Cancer Research
based on 11 papers
Top 0.8%
1.5%
19
Leukemia
based on 11 papers
Top 1%
1.3%
20
International Journal of Radiation Oncology*Biology*Physics
based on 13 papers
Top 2%
1.3%
21
Frontiers in Genetics
based on 32 papers
Top 4%
1.3%
22
PeerJ
based on 46 papers
Top 8%
1.1%
23
Journal for ImmunoTherapy of Cancer
based on 14 papers
Top 3%
0.8%
24
Nature
based on 58 papers
Top 10%
0.8%
25
JCO Precision Oncology
based on 11 papers
Top 3%
0.6%
26
Human Molecular Genetics
based on 28 papers
Top 6%
0.6%
27
JCO Clinical Cancer Informatics
based on 14 papers
Top 5%
0.6%
28
Proceedings of the National Academy of Sciences
based on 100 papers
Top 16%
0.6%